Gelesis Holdings Inc - GLS

This company is a consumer-centred biotherapeutics business advancing a novel category of treatments for weight management and gut related chronic diseases. It combined with Capstar Special Purpose Acquisition Corp in January 2021.

Shareholders meeting today to vote on the business combination with weight loss maker Gelesis. The SPAC deal is anticipated to give Gelesis an equity value of around $1.3B.